Stoke Therapeutics, Inc. (STOK) Revenue 2022–2025
Stoke Therapeutics, Inc. (STOK) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$184.4MFY2025 · since FY2022: $12.4M → $184.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $184.4M | +404.5% |
| FY2024 | $36.6M | +316.3% |
| FY2023 | $8.8M | -29.2% |
| FY2022 | $12.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More STOK financial trends
STOK Net incomeSTOK Net marginSTOK Gross profitSTOK Gross marginSTOK Operating incomeSTOK Operating marginSTOK Operating cash flowSTOK Free cash flowSTOK Capital expendituresSTOK Return on equitySTOK Stock buybacksSTOK Dividends paidSTOK Total assetsSTOK Total liabilitiesSTOK Shareholders’ equitySTOK overview →